Clanotech AB - Company Review
Clanotech AB - Company ReviewSummary
Clanotech AB (Clanotech) is a healthcare products provider that offers various anti-angiogenic compounds. The company offers VEGFRs and integrin inhibitors for the treatment of solid cancers and age related macular degeneration. Its drug discovery and optimization phases are supported by forward-chemical genetic approach, vitro identification of compounds that inhibit angiogenesis, good correlation between in vitro and in vivo efficacy, early ranking of compounds for their anti-angiogenic molecular target and time-effective decision making process. The company caters to glaucoma and wet age related macular degeneration patients. Clanotech is headquartered in Solna, Sweden.
This comprehensive company report of Clanotech AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.